219 related articles for article (PubMed ID: 31816503)
1. Novel knowledge-based treatment planning model for hypofractionated radiotherapy of prostate cancer patients.
Chatterjee A; Serban M; Faria S; Souhami L; Cury F; Seuntjens J
Phys Med; 2020 Jan; 69():36-43. PubMed ID: 31816503
[TBL] [Abstract][Full Text] [Related]
2. Target miss using PTV-based IMRT compared to robust optimization via coverage probability concept in prostate cancer.
Outaggarts Z; Wegener D; Berger B; Zips D; Paulsen F; Bleif M; Thorwarth D; Alber M; Dohm O; Müller AC
Acta Oncol; 2020 Aug; 59(8):911-917. PubMed ID: 32436467
[No Abstract] [Full Text] [Related]
3. Treatment planning comparison of IMPT, VMAT and 4π radiotherapy for prostate cases.
Tran A; Zhang J; Woods K; Yu V; Nguyen D; Gustafson G; Rosen L; Sheng K
Radiat Oncol; 2017 Jan; 12(1):10. PubMed ID: 28077128
[TBL] [Abstract][Full Text] [Related]
4. A treatment planning and acute toxicity comparison of two pelvic nodal volume delineation techniques and delivery comparison of intensity-modulated radiotherapy versus volumetric modulated arc therapy for hypofractionated high-risk prostate cancer radiotherapy.
Myrehaug S; Chan G; Craig T; Weinberg V; Cheng C; Roach M; Cheung P; Sahgal A
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e657-62. PubMed ID: 22245189
[TBL] [Abstract][Full Text] [Related]
5. Performance of Knowledge-Based Radiation Therapy Planning for the Glioblastoma Disease Site.
Chatterjee A; Serban M; Abdulkarim B; Panet-Raymond V; Souhami L; Shenouda G; Sabri S; Jean-Claude B; Seuntjens J
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):1021-1028. PubMed ID: 28870791
[TBL] [Abstract][Full Text] [Related]
6. Improving target dose coverage and organ-at-risk sparing in intensity-modulated radiotherapy of advanced laryngeal cancer by a simple optimization technique.
Lu JY; Wu LL; Zhang JY; Zheng J; Cheung ML; Ma CC; Xie LX; Huang BT
Br J Radiol; 2015 Feb; 88(1046):20140654. PubMed ID: 25494885
[TBL] [Abstract][Full Text] [Related]
7. A dosimetric comparison of RapidArc and IMRT with hypofractionated simultaneous integrated boost to the prostate for treatment of prostate cancer.
Ishii K; Ogino R; Okada W; Nakahara R; Kawamorita R; Nakajima T
Br J Radiol; 2013 Oct; 86(1030):20130199. PubMed ID: 23995872
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of mixed energy partial arcs for volumetric modulated arc therapy for prostate cancer.
Momin S; Gräfe JL; Khan RF
J Appl Clin Med Phys; 2019 Apr; 20(4):51-65. PubMed ID: 30861308
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of the factors which affect the interpatient organ-at-risk dose sparing variation in IMRT plans.
Yuan L; Ge Y; Lee WR; Yin FF; Kirkpatrick JP; Wu QJ
Med Phys; 2012 Nov; 39(11):6868-78. PubMed ID: 23127079
[TBL] [Abstract][Full Text] [Related]
10. Improved VMAT planning for head and neck tumors with an advanced optimization algorithm.
Klippel N; Schmücking M; Terribilini D; Geretschläger A; Aebersold DM; Manser P
Z Med Phys; 2015 Dec; 25(4):333-340. PubMed ID: 26071076
[TBL] [Abstract][Full Text] [Related]
11. Dominant intraprostatic lesion boosting in sexual-sparing radiotherapy of prostate cancer: A planning feasibility study.
Ciabatti S; Ntreta M; Buwenge M; Gaudiano C; Sessagesimi E; Romani F; Angelini AL; Cammelli S; Macchia G; Deodato F; Zamagni A; Golfieri R; Morganti AG; Cilla S
Med Dosim; 2019 Winter; 44(4):356-364. PubMed ID: 30955990
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of Multi-Criteria Optimization-based Trade-Off exploration in combination with RapidPlan for head & neck radiotherapy planning.
Miguel-Chumacero E; Currie G; Johnston A; Currie S
Radiat Oncol; 2018 Nov; 13(1):229. PubMed ID: 30470254
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy treatment plans with RapidArc for prostate cancer involving seminal vesicles and lymph nodes.
Yoo S; Wu QJ; Lee WR; Yin FF
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):935-42. PubMed ID: 20044214
[TBL] [Abstract][Full Text] [Related]
14. Clinical validation and benchmarking of knowledge-based IMRT and VMAT treatment planning in pelvic anatomy.
Hussein M; South CP; Barry MA; Adams EJ; Jordan TJ; Stewart AJ; Nisbet A
Radiother Oncol; 2016 Sep; 120(3):473-479. PubMed ID: 27427380
[TBL] [Abstract][Full Text] [Related]
15. A new predictive parameter for dose-volume metrics in intensity-modulated radiation therapy planning for prostate cancer: Initial phantom study.
Saito Y; Suzuki R; Miyamoto N; Sutherland KL; Kanehira T; Tamura M; Mori T; Nishioka K; Hashimoto T; Aoyama H
J Appl Clin Med Phys; 2024 Apr; 25(4):e14250. PubMed ID: 38146130
[TBL] [Abstract][Full Text] [Related]
16. Results of a multicenter intensity modulated radiation therapy treatment planning comparison study for a sample prostate cancer case.
Frenzel T; Albers D; Grohmann M; Krüll A
Strahlenther Onkol; 2019 Oct; 195(10):913-922. PubMed ID: 31342106
[TBL] [Abstract][Full Text] [Related]
17. Advancing knowledge-based intensity modulated proton planning for adaptive treatment of high-risk prostate cancer.
Johnson CL; Hasan S; Huang S; Lin H; Gorovets D; Shim A; Apgar T; Yu F; Tsai P
Med Dosim; 2024 Spring; 49(1):19-24. PubMed ID: 37914563
[TBL] [Abstract][Full Text] [Related]
18. The role of adaptive planning in margin-reduced, MRI-guided stereotactic body radiotherapy to the prostate bed following radical prostatectomy: Post-hoc analysis of a phase II clinical trial.
Nikitas J; Smith LM; Gao Y; Ma TM; Sachdeva A; Yoon SM; Jiang T; Low DA; Ballas LK; Steinberg ML; Cao M; Kishan AU
Radiother Oncol; 2023 Jun; 183():109631. PubMed ID: 36934894
[TBL] [Abstract][Full Text] [Related]
19. A knowledge-based quantitative approach to characterize treatment plan quality: Application to prostate VMAT planning.
Alnaalwa B; Nwankwo O; Abo-Madyan Y; Giordano FA; Wenz F; Glatting G
Med Phys; 2021 Jan; 48(1):94-104. PubMed ID: 33119944
[TBL] [Abstract][Full Text] [Related]
20. Can knowledge-based DVH predictions be used for automated, individualized quality assurance of radiotherapy treatment plans?
Tol JP; Dahele M; Delaney AR; Slotman BJ; Verbakel WF
Radiat Oncol; 2015 Nov; 10():234. PubMed ID: 26584574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
